Welcome to our dedicated page for Apptly Health Technologies news (Ticker: ESVNF), a resource for investors and traders seeking the latest updates and insights on Apptly Health Technologies stock.
UBERDOC Health Technologies Corp. operates a direct-pay healthcare marketplace that connects patients with physicians and specialists at transparent, upfront prices. Company news centers on its specialty-care platform, direct-access healthcare model, employer-benefits positioning, and developments tied to public-market operations.
Recurring updates also cover the company's completed amalgamation with ROV Investment Partners, its transition from the former Serra Energy Metals issuer profile, Canadian Securities Exchange and Frankfurt trading references, market-making arrangements, capital-structure actions, and board governance changes.
Apptly Health Technologies (CSE: APPT, FSE: 4KL, OTC: ESVNF), operator of the UberDoc direct-pay healthcare marketplace, appointed four physicians to its Advisory Board: Dr. Eric Bricker, Dr. Diana Girnita, Dr. Cristin Dickerson, and Dr. Fred Liss.
Their backgrounds span healthcare finance, direct-pay specialty care, employer-sponsored healthcare, and physician-led organizations, which Apptly expects will support expansion of its nationwide direct-pay marketplace, physician network, and employer and hospital relationships.
Apptly Health (CSE: APPT, OTC: ESVNF), operator of UberDoc, signed a three-year Strategic Collaboration Agreement with Emphera Health effective July 1, 2026. UberDoc supplies direct-pay consultation and booking technology while Emphera manages outpatient clinical and surgical services.
The deal includes profit-sharing mechanisms, should add about 2,000 specialists to UberDoc, expanding its network from 5,000 to over 7,000, and targets self-funded employers, leveraging Emphera contracts that serve a total addressable population of more than 40 million people.
Apptly Health Technologies (CSE: APPT, OTC: ESVNF), operator of the UberDoc direct-pay healthcare marketplace, appointed Lemonaid Health co-founder Paul Johnson to its advisory board as it scales nationwide.
The company also changed its name from UberDoc Health Technologies, maintained ticker APPT, and engaged Focus Communications for C$60,000 in investor relations services.
UBERDOC Health Technologies Corp. (CSE: APPT, FSE: 4KL0) plans to change its corporate name to Apptly Health Technologies Corp. around June 23, 2026, subject to approvals.
The rebrand reflects its evolution into a direct-pay healthcare marketplace built on a 5,000+ physician network across 55+ specialties, with no change to share count, rights, or operations. Director Sean Kearney resigned June 9, 2026.
UBERDOC Health Technologies (ESVNF) appointed John Dvor to its Board of Directors as it scales its nationwide direct-pay specialty care marketplace and expands strategic partnerships.
Dvor brings experience in healthcare technology, therapeutics, and venture leadership. UberDoc’s platform includes over 5,000 board-certified specialists across all 50 states.
UberDoc Health Technologies (ESVNF) announced a leadership transition as the company enters its next growth phase. Former CEO Sean Kearney has departed, and founder Dr. Paula Muto has been appointed Interim CEO effective May 15, 2026.
According to UberDoc, Kearney helped guide listings on the Canadian and Frankfurt exchanges and strengthen operations. Dr. Muto, a board-certified vascular surgeon, will focus on expanding the physician network and accelerating consumer adoption while the Board conducts a permanent CEO search.
UberDoc Health Technologies Corp (ESVNF) announced on April 24, 2026 that Jeffrey Hogan has stepped down from its Board of Directors to focus on the Judi Group, a healthcare advisory firm he co-founded in January 2026. Hogan contributed four decades of employer-sponsored healthcare and benefits strategy experience while on the board. Management thanked him for his work shaping UberDoc's positioning in the employer benefits market as employers shift toward cost-transparent, direct-access care models.
UberDoc (OTC: ESVNF) announced that Founder Dr. Paula Muto was appointed to the National Committee on Vital and Health Statistics (NCVHS), advising HHS and CMS on health data, privacy, and standards. The appointment follows UberDoc's recent public listings and precedes an investor webinar on April 15, 2026.
Dr. Muto remains a practicing vascular surgeon, chief medical advisor, and board member as the company expands its direct-pay specialty network across the U.S.
UberDoc Health Technologies (ESVNF) engaged Independent Trading Group (ITG) as a market maker on the Canadian Securities Exchange effective March 19, 2026.
The agreement aims to maintain a reasonable market and improve liquidity. It is an initial one-month term, auto-renewable monthly, terminable on 30 days' notice; ITG receives no shares or options.
UBERDOC Health Technologies Corp (OTCQB: ESVNF) completed a three-cornered amalgamation with ROV Investment Partners on March 13, 2026 and listed on the Canadian Securities Exchange as APPT effective March 18, 2026.
The transaction resulted in a post-close ownership split of 12.3% existing company holders and 87.7% ROV shareholders, raised gross proceeds of approximately $3,010,241.55, and issued warrants exercisable at $0.50 for two years.